Anthony M. Nicasio, Pharm.D.

Assistant Professor
Department of Pharmacy Practice, Albany Campus
Tel: (518) 694-7324
E-mail: anthony.nicasio@acphs.edu

Education:

• Infectious Diseases Pharmacotherapy Fellowship, Center for Anti-Infective Research and Development, Hartford, CT
  
  Infectious Diseases Pharmacy Resident, Center for Anti-Infective Research and Development & Hartford Hospital, Hartford, CT
  
  Pharm.D., University of Michigan, Ann-Arbor, MI

Courses Taught at ACPHS:

• > PTPM (Infectious Disease Module)
• > Integrated Problem Solving
• > Clinical Pharmacogenomics

Research Interests:

• Dr. Nicasio’s research focuses on ways of optimizing antibiotic efficacy when used to treat prevalent multi-drug resistant bacterial infections. Specifically, he utilizes various experimental methodologies to evaluate the impact that antibiotic dosing strategies (e.g., pharmacokinetic-pharmacodynamic principles and combination therapy) have on the rate and extent of bacterial kill, the development of antibiotic resistance, and the survival of the patient.

Honors and Achievements:

• Infectious Diseases Society of America & Interscience Conference on Antimicrobial Agents and Chemotherapy Fellows Travel Grant Recipient. Awarded to infectious diseases fellows in recognition of excellence in abstract submission to the Annual Meeting (2008).
  
  Making a Difference in Infectious Diseases Pharmacotherapy Abstract Award Recipient. Awarded to an infectious diseases fellow or resident in recognition of excellence in abstract submission to the MAD-ID Annual Meeting (2008).
  
  The #1 viewed article in the peer-reviewed journal, Pharmacotherapy, in 2008, as cited in the ACCP Report 2009; 28 (2): 1-19.

Selected Peer-Reviewed Publications (Original Research):

• Nicasio AM, Bullita JB, Lodise TP, D’Hondt RE, Kulawy R, Louie A, Drusano GL. Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow fiber infection model. Antimicrobial Agents and Chemotherapy. 2012;56(2):682-6.
  
  Wiskirchen DE, Koomanachai P, Nicasio AM, Nicolau DP, Kuti JL. In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase. Antimicrobial Agents and Chemotherapy. 2011;55(4):1420-7.
  Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP. Optimization of meropenem dosage in the critically ill population based on renal function.Intensive Care Medicine. 2011;37(4):632-8.
  
  Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL. Hospital costs and length of stay associated with a pharmacodynamic based clinical pathway for empiric antibiotic choice in patients with ventilator associated pneumonia. Pharmacotherapy. 2010;30(5):453-62.
  
  Nicasio AM, Eagye KJ, Nicolau DP, Shore E, Palter M, Pepe J, Kuti JL. A pharmacodynamic based clinical pathway for empiric antibiotic choice in patients infected with ventilator associated pneumonia. Journal of Critical Care. 2010;25:69-77.
  
  Nicasio AM, Crandon JL, Nicolau DP. In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 2009;53(7):2756-61.
  
  Kuti JL, Nicasio AM, Sutherland CA, Nicolau DP. Elevated vancomycin minimum inhibitory concentrations among methicillin-resistant Staphylococcus aureus causing ventilator associated pneumonia at a Connecticut Hospital. Connecticut Medicine. 2009; 73(6):337-40.
  
  Nicasio AM, Ariano RE, Zelenitsky SA, Kim A, Crandon JL, Kuti JL, Nicolau DP. Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically-ill patients with ventilator associated pneumonia. Antimicrobial Agents and Chemotherapy. 2009;53(4):1476-81.
  
  Nicasio AM, Tessier PT, Nicolau DP, Knauft RF, Russomanno J, Shore E, Kuti JL. Bronchopulmonary disposition of micafungin in healthy adult volunteers. Antimicrobial Agents and Chemotherapy. 2009; 53(3):1218-20.
  
  Nicasio AM, Kuti JL, Aslanzadeh J, Nicolau DP. Influence of automated testing and identification on extended spectrum β-lactamase producing Enterobacteriaceae on antibiotic prescribing. Journal of Medical Microbiology. 2008; 57(Pt9):1147-51.